Supplementation therapy and Conjunctivitis aggravated

Summary:

Conjunctivitis aggravated is found among people with Supplementation therapy, especially for people who are female, 60+ old.

The study analyzes which people have Conjunctivitis aggravated with Supplementation therapy. It is created by eHealthMe based on reports of 50 people who have Supplementation therapy from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Supplementation therapy?

Supplementation therapy is found to be associated with 3 drugs and 7 conditions by eHealthMe. Check the latest studies of Supplementation therapy.

What is Conjunctivitis aggravated?

Conjunctivitis aggravated (infection of conjunctiva) is found to be associated with 1,045 drugs and 366 conditions by eHealthMe. Check the latest studies of Conjunctivitis aggravated.



On Jul, 16, 2026

50 people who have Supplementation Therapy and Conjunctivitis Aggravated are studied.

Would you have Conjunctivitis aggravated when you have Supplementation therapy?

Gender of people who have Supplementation Therapy and experienced Conjunctivitis Aggravated *:

  • female: 80.43 %
  • male: 19.57 %

Age of people who have Supplementation Therapy and experienced Conjunctivitis Aggravated *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 2.63 %
  • 30-39: 2.63 %
  • 40-49: 7.89 %
  • 50-59: 2.63 %
  • 60+: 84.21 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 18 people, 36.00%
  2. High Blood Cholesterol: 14 people, 28.00%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 12 people, 24.00%
  4. Pain: 11 people, 22.00%
  5. Asthma: 11 people, 22.00%
  6. Hypersensitivity: 11 people, 22.00%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 11 people, 22.00%
  8. Osteopenia (a condition where bone mineral density is lower than normal): 10 people, 20.00%
  9. Dizziness: 10 people, 20.00%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 10 people, 20.00%

Common drugs taken by these people *:

  1. Calcium: 16 people, 32.00%
  2. Advair Hfa: 10 people, 20.00%
  3. Potassium: 10 people, 20.00%
  4. Proair Hfa: 10 people, 20.00%
  5. Antivert: 9 people, 18.00%
  6. Peridex: 9 people, 18.00%
  7. Breo Ellipta: 9 people, 18.00%
  8. Nasonex: 9 people, 18.00%
  9. Xeljanz: 9 people, 18.00%
  10. Folic Acid: 8 people, 16.00%

Common symptoms for these people *:

  1. Diarrhea: 15 people, 30.00%
  2. Rashes (redness): 14 people, 28.00%
  3. Urinary Tract Infection: 13 people, 26.00%
  4. Pneumonia: 13 people, 26.00%
  5. Nasopharyngitis (inflammation of the nasopharynx): 11 people, 22.00%
  6. Nausea And Vomiting: 11 people, 22.00%
  7. Pain: 10 people, 20.00%
  8. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall): 10 people, 20.00%
  9. Gait Disturbance: 10 people, 20.00%
  10. High Blood Cholesterol: 10 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Conjunctivitis aggravated?

- Check whether Conjunctivitis aggravated is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Conjunctivitis aggravated:

All the conditions that are associated with Conjunctivitis aggravated:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Conjunctivitis aggravated and Supplementation therapy, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: